Larson Financial Group’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.6K Sell
737
-196
-21% -$17.4K ﹤0.01% 1177
2025
Q4
$75K Buy
933
+141
+18% +$11.8K ﹤0.01% 1050
2025
Q3
$77.3K Buy
792
+55
+7% +$4.43K ﹤0.01% 995
2025
Q2
$51.4K Buy
737
+453
+160% +$25.8K ﹤0.01% 1061
2025
Q1
$14.1K Buy
284
+260
+1,083% +$16.4K ﹤0.01% 1496
2024
Q4
$1.68K Sell
24
-100
-81% -$8.3K ﹤0.01% 1921
2024
Q3
$13K Buy
124
+122
+6,100% +$14.3K ﹤0.01% 1373
2024
Q2
$284 Buy
+2
New +$231 ﹤0.01% 1973

Other funds holding ACLS

Larson Financial Group's ACLS Position: Q1 2026 in Review

Larson Financial Group reduced its Axcelis (ACLS) stake by 21% in Q1 2026, selling an estimated $17.4K and leaving 737 shares worth $68.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

Larson Financial Group first reported a position in ACLS in Q2 2024 and has held it in 8 quarters since. The position peaked at $77.3K in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Larson Financial Group held 737 shares of Axcelis worth $68.6K as of Q1 2026.
  • Larson Financial Group sold 196 Axcelis shares in Q1 2026, an estimated $17.4K.
  • Axcelis made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1177 holding.
  • Larson Financial Group first reported a position in Axcelis in Q2 2024 and has held it in 8 quarters since.
  • Larson Financial Group's Axcelis position peaked at $77.3K in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.